Lin Zhang
-
- Cardiac Valve Diseases and Treatments 14
- Cardiac electrophysiology and arrhythmias 14
- Atrial Fibrillation Management and Outcomes 7
- Molecular Biology top 5%
- Inflammasome and immune disorders 15
- Ion channel regulation and function 12
- Angiogenesis and VEGF in Cancer 9
- Sphingolipid Metabolism and Signaling 8
- Cancer Research top 5%
- Immunology top 10%
- Sensory Systems top 5%
-
- Infective Endocarditis Diagnosis and Management 9
Lin Zhang
134 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 151
- Cardiology and Cardiovascular Medicine 1.7k
- Molecular Biology 2.2k
- Cancer Research 316
- Immunology 377
- Sensory Systems 85
Countries citing papers authored by Lin Zhang
This map shows the geographic impact of Lin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhang more than expected).
Fields of papers citing papers by Lin Zhang
This network shows the impact of papers produced by Lin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhang. The network helps show where Lin Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 10 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 1 | |
| 12 | T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease | 2022 | 10 |
| 13 | 2022 | 8 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 31 | |
| 16 | 2021 | 1 | |
| 17 | 2020 | 13 | |
| 18 | 2015 | 3 | |
| 19 | Validity evaluation of dipstick dye immuno-assay (DDIA) for screening in low endemic areas of schistosomiasis. | 2010 | 3 |
| 20 | Different Characteristics of Heart Rate Variability in Mental and Physical Fatigue States | 2010 | 3 |
About Lin Zhang
Lin Zhang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research, having authored 140 papers that have together received 3.7k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (15 papers), Cardiac Valve Diseases and Treatments (14 papers), Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (12 papers), Angiogenesis and VEGF in Cancer (9 papers), Infective Endocarditis Diagnosis and Management (9 papers), Sphingolipid Metabolism and Signaling (8 papers) and Atrial Fibrillation Management and Outcomes (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.7k citations), Molecular Biology (2.2k citations) and Cancer Research (316 citations). Lin Zhang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Dawei Jiang, Bailong Xiao, Ruiwu Wang, Philip Choi, S.R. Wayne Chen, Heping Cheng, Huihui Kong, Dongmei Yang, Min Zeng and Bingmei M. Fu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.